# A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)

> **NCT00564954** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 86 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Dex-methylphenidate hydrochloride extended-release (Focalin XR)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00564954
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2012-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00564954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00564954, "A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00564954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*